Crossmark

Prognostic utility of mid-regional pro-adrenomedullin and growth differentiation factor 15 in patients undergoing transfemoral transcatheter aortic valve implantation

Crossref DOI link: https://doi.org/10.1007/s00392-024-02560-w

Published Online: 2024-10-25

Published Print: 2025-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Piayda, Kerstin

Keranov, Stanislav

Schulz, Luisa

Arsalan, Mani

Liebetrau, Christoph

Kim, Won-Keun

Hofmann, Felsix J.

Bauer, Pascal

Voss, Sandra

Troidl, Christian

Sossalla, Samuel T.

Hamm, Christian W.

Nef, Holger M.

Dörr, Oliver https://orcid.org/0000-0003-4526-6956
Funding

Funding for this research was provided by:

Collaborative Research Center 1213-Pulmonary Hypertension and Cor Pulmonale, German Research Foundation

Justus-Liebig-Universität Gießen
License Information

Text and Data Mining valid from 2024-10-25

Version of Record valid from 2024-10-25
More Information

Article History

Received: 3 March 2024

Accepted: 7 October 2024

First Online: 25 October 2024

Declarations

:

: All authors have nothing to disclose relevant to the present work.

Document is current

Any future updates will be listed below